Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 08:26 am Purchase | 2026-03-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW Investments, LP | 12,356,953 9.900% | 3,201,785 (+34.97%) | Filing History |
| 2026-05-13 09:09 am Sale | 2026-03-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Adage Capital Management, L.P. | 8,000,000 6.370% | -659,064 (-7.61%) | Filing History |
| 2026-03-26 5:37 pm Sale | 2026-03-20 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 5,333,333 4.300% | -3,684,547 (-40.86%) | Filing History |
| 2025-12-23 2:20 pm Purchase | 2025-07-11 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Propel Bio Management LLC | 8,861,186 9.900% | 8,861,186 (New Position) | Filing History |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 9,017,880 9.900% | 169,998 (+1.92%) | Filing History |
| 2025-11-14 08:30 am Purchase | 2025-09-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW Investments, LP | 9,155,168 9.900% | 3,514,575 (+62.31%) | Filing History |
| 2025-11-13 09:10 am Purchase | 2025-09-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Adage Capital Management, L.P. | 8,659,064 9.990% | 8,659,064 (New Position) | Filing History |
| 2025-07-21 4:30 pm Purchase | 2025-07-14 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Trails Edge Capital Partners, LP | 8,847,882 9.900% | 8,847,882 (New Position) | Filing History |
| 2025-04-30 4:00 pm Sale | 2025-03-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 322,082 0.600% | -2,456,443 (-88.41%) | Filing History |
| 2025-04-22 09:32 am Sale | 2025-03-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock, Inc. BLK | 0 0.000% | -4,050,686 (Position Closed) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW Investments, LP | 5,640,593 9.990% | 2,285,768 (+68.13%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock, Inc. BLK | 4,050,686 7.600% | 779,937 (+23.85%) | Filing History |
| 2024-10-29 4:30 pm Purchase | 2024-09-30 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 2,778,525 5.200% | 1,047,636 (+60.53%) | Filing History |
| 2024-07-16 6:06 pm Purchase | 2024-07-14 | 13D | MILESTONE PHARMACEUTICALS INC MIST | Alta Fundamental Advisers LLC | 2,658,589 4.990% | 987,300 (+59.07%) | Filing History |
| 2024-02-14 8:56 pm Sale | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III, L.P. | 925,048 2.800% | -1,283,764 (-58.12%) | Filing History |
| 2024-02-14 07:10 am Sale | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW Investments, LP | 3,354,825 9.990% | -960,277 (-22.25%) | Filing History |
| 2024-02-09 7:41 pm Sale | 2023-12-29 | 13G | MILESTONE PHARMACEUTICALS INC MIST | GOLDMAN SACHS GROUP INC GS | 1,359,540 4.100% | -1,390,845 (-50.57%) | Filing History |
| 2024-01-29 4:42 pm Sale | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 1,730,889 5.200% | -464,140 (-21.15%) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | BlackRock, Inc. BLK | 3,270,749 9.800% | 1,542,920 (+89.30%) | Filing |
| 2023-11-09 4:43 pm Purchase | 2023-11-06 | 13D | MILESTONE PHARMACEUTICALS INC MIST | Alta Fundamental Advisers LLC | 1,671,289 5.000% | 1,671,289 (New Position) | Filing History |